These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 24524817)

  • 1. Clinical significance of the neutrophil-lymphocyte ratio in venous thromboembolism patients with lung cancer.
    Go SI; Lee A; Lee US; Choi HJ; Kang MH; Kang JH; Jeon KN; Park MJ; Kim SH; Lee GW
    Lung Cancer; 2014 Apr; 84(1):79-85. PubMed ID: 24524817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil-Lymphocyte Ratio is a Predictor of Venous Thromboembolism in Gastric Cancer Patients.
    Du P
    Clin Lab; 2019 May; 65(5):. PubMed ID: 31115236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venous thromboembolism risk prediction in ambulatory cancer patients: clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio.
    Ferroni P; Riondino S; Formica V; Cereda V; Tosetto L; La Farina F; Valente MG; Vergati M; Guadagni F; Roselli M
    Int J Cancer; 2015 Mar; 136(5):1234-40. PubMed ID: 25042739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil-Lymphocyte Ratio as a Predictor of Venous Thromboembolism after Total Knee Replacement.
    Seo WW; Park MS; Kim SE; Lee JH; Park DG; Han KR; Oh DJ; Hyon MS
    J Knee Surg; 2021 Jan; 34(2):171-177. PubMed ID: 31394586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of the absolute monocyte counts in lung cancer patients with venous thromboembolism.
    Go SI; Kim RB; Song HN; Kang MH; Lee US; Choi HJ; Jo W; Lee SJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Kim SH; Kang JH; Lee GW
    Tumour Biol; 2015 Sep; 36(10):7631-9. PubMed ID: 25921284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neutrophil-to-lymphocyte ratio predicts the survival in patients with post-operative recurrence of non-small cell lung cancer].
    Wang X; Li K
    Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):298-302. PubMed ID: 24989918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thromboembolism in patients with cholangiocarcinoma: focus on risk factors and impact on survival.
    Jeon HK; Kim DU; Baek DH; Ha DW; Lee BE; Ryu DY; Cheong JH; Kim GH; Song GA; Jang AL
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):444-9. PubMed ID: 22410715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and clinical significance of incidental and clinically suspected venous thromboembolism in lung cancer patients.
    Connolly GC; Menapace L; Safadjou S; Francis CW; Khorana AA
    Clin Lung Cancer; 2013 Nov; 14(6):713-8. PubMed ID: 23891560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous Thromboembolism Is an Independent Predictor of Mortality Among Patients with Gastric Cancer.
    Fuentes HE; Oramas DM; Paz LH; Wang Y; Andrade XA; Tafur AJ
    J Gastrointest Cancer; 2018 Dec; 49(4):415-421. PubMed ID: 28634671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous thromboembolism and nonsmall cell lung cancer: a pooled analysis of National Cancer Institute of Canada Clinical Trials Group trials.
    Hicks LK; Cheung MC; Ding K; Hasan B; Seymour L; Le MaƮtre A; Leighl NB; Shepherd FA
    Cancer; 2009 Dec; 115(23):5516-25. PubMed ID: 19711465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy.
    Yao Y; Yuan D; Liu H; Gu X; Song Y
    Cancer Immunol Immunother; 2013 Mar; 62(3):471-9. PubMed ID: 22986452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the nonspecific inflammatory markers in determining the anatomic extent of venous thromboembolism.
    Bakirci EM; Topcu S; Kalkan K; Tanboga IH; Borekci A; Sevimli S; Acikel M
    Clin Appl Thromb Hemost; 2015 Mar; 21(2):181-5. PubMed ID: 23814171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil:lymphocyte ratio as a simple and novel biomarker for prediction of locoregional recurrence after chemoradiotherapy for squamous cell carcinoma of the anus.
    Toh E; Wilson J; Sebag-Montefiore D; Botterill I
    Colorectal Dis; 2014 Mar; 16(3):O90-7. PubMed ID: 24148256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative plasma D-dimer levels predict survival in patients with operable non-small cell lung cancer independently of venous thromboembolism.
    Zhang PP; Sun JW; Wang XY; Liu XM; Li K
    Eur J Surg Oncol; 2013 Sep; 39(9):951-6. PubMed ID: 23810331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-lymphocyte ratio is a predictor of venous thromboembolism in cancer patients.
    Yang W; Liu Y
    Thromb Res; 2015 Aug; 136(2):212-5. PubMed ID: 25533129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of preoperative neutrophil-lymphocyte vs platelet-lymphocyte ratio in primary operable patients with non-small cell lung cancer.
    Zhang H; Xia H; Zhang L; Zhang B; Yue D; Wang C
    Am J Surg; 2015 Sep; 210(3):526-35. PubMed ID: 26105800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of preoperative neutrophil-to-lymphocyte ratio as a predictor of prognosis in patients with stage IV colorectal cancer].
    Shibutani M; Maeda K; Nagahara H; Noda E; Ohtani H; Sugano K; Takii M; Kimura K; Toyokawa T; Amano R; Kubo N; Tanaka H; Muguruma K; Ohira M; Hirakawa K
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1603-5. PubMed ID: 24393862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incidence, risk factors, and prognosis of recurrent venous thromboembolism (VTE) in patients with advanced solid cancers receiving anticoagulation therapy after the diagnosis of index VTE.
    Yhim HY; Jang MJ; Kwak JY; Yim CY; Choi WI; Lee YC; Lee JO; Lee KW; Bang SM; Kim SH; Kim YK; Chang HJ; Oh D;
    Thromb Res; 2013 Apr; 131(4):e133-40. PubMed ID: 23399441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical analysis of postoperative venous thromboembolism risk factors in lung cancer patients.
    Yang Y; Zhou Z; Niu XM; Li ZM; Chen ZW; Jian H; Ai XH; Cheng BJ; Liao ML; Lu S
    J Surg Oncol; 2012 Nov; 106(6):736-41. PubMed ID: 22711667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated preoperative inflammatory markers based on neutrophil-to-lymphocyte ratio and C-reactive protein predict poor survival in resected non-small cell lung cancer.
    Tomita M; Shimizu T; Ayabe T; Nakamura K; Onitsuka T
    Anticancer Res; 2012 Aug; 32(8):3535-8. PubMed ID: 22843942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.